OncoMed

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
biotech
Sarepta Therapeutics
OncoMed
Vivus
MannKind
Myriad Genetics
OncoMed Commences Study on OMP-54F28
Yahoo/Zacks
Sat, 02/22/14 - 10:54 am
OncoMed
OMP-54F28
ovarian cancer
Positive Oncology News Lifts OncoMed
Yahoo/Zacks.com
Mon, 01/20/14 - 07:00 pm
OncoMed
OMP-59R5
demcizumab
pancreatic cancer
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
Neostem Stands To Benefit From Stem-Cell Deals
Seeking Alpha
Mon, 12/23/13 - 10:05 am
NeoStem
stem cells
Celgene
OncoMed
Is BIND Therapeutics Ready To Fly Higher?
Seeking Alpha
Fri, 12/13/13 - 08:28 am
Bind Therapeutics
OncoMed
Who Benefits From the OncoMed and Celgene Partnership?
Motley Fool
Wed, 12/4/13 - 12:08 pm
OncoMed
Celgene
OncoMed Shares Jump After Signing Deal With Celgene
Bloomberg
Tue, 12/3/13 - 09:49 am
OncoMed
Celgene
OncoMed initiates second Phase 1b clinical trial of vantictumab
Yahoo/AP
Fri, 11/15/13 - 11:25 am
OncoMed
vantictumab
non-small cell lung cancer
Fresh burst of biotech IPO pitches launches a busy Q4 season
Fierce Biotech
Tue, 10/22/13 - 11:51 am
IPOs
Foundation Medicine
Ophthotech
Intrexon
Onconova
Agios
OncoMed
OncoMed presents data from trials of four anti-CSC therapeutics
The Fly on the Wall
Mon, 10/21/13 - 04:14 pm
OncoMed
anti-CSC
OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:32 pm
vantictumab
OMP-18R5
neuroendocrine tumors
OncoMed
solid tumors
OncoMed granted additional broad anti-RSPO antibody patent in U.S.
Yahoo/Fly on the Wall
Wed, 09/25/13 - 09:03 am
OncoMed
anti-RSPO
patents
antibodies
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
OncoMed: High Opening Day Returns For This Biotech Public Offering
Seeking Alpha
Sat, 07/20/13 - 11:52 am
OncoMed
The Deal: OncoMed IPO Goes Metastatic
TheStreet.com
Fri, 07/19/13 - 11:45 am
IPOs
OncoMed
stem cells
Genomic Health, OncoMed to pursue companion diagnostics
Thu, 05/3/12 - 11:02 pm
Genomic Health
OncoMed
diagnostics
10 Biotechs Targeting Cancer Stem Cell Destruction
Minyanville
Mon, 03/5/12 - 11:51 am
stem cells
Stemica
OncoMed
KaloBios
Stemline
Formula Pharmaceuticals
Eclipse Pharmaceuticals
Verastem
ImmunoCellular
Geron
EntreMed
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
Bloomberg
Mon, 01/31/11 - 07:53 am
MorphoSys
Pfizer
OncoMed
Bayer Agrees to Develop Cancer Medicines With OncoMed
Bloomberg
Thu, 06/17/10 - 06:55 pm
OncoMed
partnerships
Bayer
cancer

Pages